z-logo
open-access-imgOpen Access
Real-world effectiveness of early remdesivir and sotrovimab in the highest-risk COVID-19 outpatients during the Omicron surge
Author(s) -
Nicholas Piccicacco,
Kristen Zeitler,
Austin Ing,
José Montero,
Jonathan Faughn,
Suzane Silbert,
Kami Kim
Publication year - 2022
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkac256
Subject(s) - medicine , covid-19 , emergency department , incidence (geometry) , retrospective cohort study , clinical endpoint , cohort , adverse effect , cohort study , emergency medicine , pediatrics , randomized controlled trial , disease , physics , psychiatry , infectious disease (medical specialty) , optics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom